SPIRIT V Registry: Adjudicated Composite rate of All Death, Myocardial Infarction (MI) and Target Vessel Revascularization (TVR) . at 30 days [clinicaltrials_resource:484fed2aaaed557af64df710797c0624]
XIENCE V® Everolimus Eluting Coronary Stent System
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
SPIRIT V Registry: Adjudicated Composite rate of All Death, Myocardial Infarction (MI) and Target Vessel Revascularization (TVR) . at 30 days [clinicaltrials_resource:484fed2aaaed557af64df710797c0624]
XIENCE V® Everolimus Eluting Coronary Stent System
Bio2RDF identifier
484fed2aaaed557af64df710797c0624
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:484fed2aaaed557af64df710797c0624
measure [clinicaltrials_vocabulary:measure]
SPIRIT V Registry: Adjudicated ...... ssel Revascularization (TVR) .
time frame [clinicaltrials_vocabulary:time-frame]
at 30 days
description
XIENCE V® Everolimus Eluting Coronary Stent System
identifier
clinicaltrials_resource:484fed2aaaed557af64df710797c0624
title
SPIRIT V Registry: Adjudicated ...... ularization (TVR) . at 30 days
@en
type
label
SPIRIT V Registry: Adjudicated ...... fed2aaaed557af64df710797c0624]
@en